Table 2.
Car-T cell therapy for hematological malignancies
| Disease | Full name | Antigen | Some Clinical trials |
|---|---|---|---|
| ALL | acute lymphoblastic leukemia | CD19/CD20/CD22/CD123 | NCT04012879; NCT04049383; NCT04094766; NCT04016129 |
| CLL | Chronic lymphoblastic leukemia | CD19 | NCT04007029; NCT03960840 |
| NHL | non-Hodgkin lymphoma | CD19/CD20 | NCT03790891; NCT03497533; NCT04169932 |
| ALCL | anaplastic large cell lymphoma | CD30 | NCT03383965; NCT04008394 |
| HL | Hodgkin lymphoma | CD19/CD30 | NCT01087294; NCT04134325 |
| MM | Multiple myeloma | CD269/CD138 | NCT03672318; NCT04182581; NCT03271632 |